Antibody Information
General Information of This Antibody
| Antibody ID | ANI0VALRO |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | pH-dependent antic-MET antibody |
|||||
| Organization | Mythic Therapeutics, Inc. |
|||||
| Synonyms |
pH-dependent antic-MET antibody
Click to Show/Hide
|
|||||
| Antibody Type | Monoclonal antibody (mAb) |
|||||
| Antigen Name | Hepatocyte growth factor receptor (MET) |
Antigen Info | ||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
MYTX-011 [Phase 1]
Identified from the Human Clinical Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Related Clinical Trial | |||||
| NCT Number | NCT05652868 | Clinical Status | Phase 1 | ||
| Clinical Description |
A phase 1 multicenter dose escalation and dose expansion study of antibody-drug conjugate MYTX-011 in subjects with non-small cell lung cancer - kismet-01.
|
||||
References